Updated:
Jun Yuan Capital
Jun Yuan Capital is a venture capital firm that invests in technology companies. It has made 10 investments, including a Series A investment in Jiangsu Lianbo...
Jun Yuan Capital
Jun Yuan Capital is a venture capital firm that invests in technology companies. It has made 10 investments, including a Series A investment in Jiangsu Lianbo Precision Technology on November 05, 2021. The firm has 2 portfolio exits, with Royal Bio-Pharmaceutical being its latest exit on June 11, 2019.
General information
Firm type
Private Equity
Year founded
2014
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Principals
Li Chao
Founding Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Jun Yuan Capital?
Founding Partner Li Chao leads the firm. The investment committee structure and any additional senior partners have not been publicly detailed. Jun Yuan operates from a single Beijing office and does not publish biographies of its broader team.
Which sectors does Jun Yuan Capital explicitly avoid?
Jun Yuan has no publicly stated avoidance policy. However, its disclosed portfolio contains no consumer-internet, real-estate platform, or entertainment holdings. The firm's observed posture is a concentrated bet on enterprise technology, industrial automation, and energy transition.
Does Jun Yuan participate in fund commitments or only direct deals?
The firm operates as a direct investor, taking equity positions in individual operating companies. There is no public record of Jun Yuan acting as a fund-of-funds or committing capital to external GPs.
How does Jun Yuan differentiate itself from other Chinese tech investors?
The firm committed to enterprise and industrial technology before the 2018–2020 market rotation away from consumer platforms. Its consistent mandate through both the consumer-internet boom and the subsequent regulatory reset distinguishes it from managers that repositioned reactively.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: